Checkpoint Surgical

Executive Summary

Checkpoint Surgical is a privately held medical device company based in Cleveland, Ohio, dedicated to advancing peripheral nerve surgery. Since its founding in 2008, the company has developed and commercialized a comprehensive portfolio of intraoperative nerve stimulation devices, biomaterial implants, and specialized surgical instruments. These products have become a standard of care in peripheral nerve procedures, helping surgeons protect and repair nerves more effectively. The company’s technology addresses a critical need in nerve-sparing surgeries, reducing the risk of nerve damage and improving patient outcomes. With a focus on innovation and clinical utility, Checkpoint Surgical has established a strong presence in the neurosurgical and orthopedic markets. Looking ahead, Checkpoint Surgical is poised for continued growth driven by several near-term catalysts. The company is expected to expand its product line with next-generation nerve monitoring devices and advanced biomaterial implants, potentially securing additional FDA clearances. Ongoing clinical studies are anticipated to generate further evidence supporting the efficacy of its products, which could drive adoption in larger hospitals and surgical centers. Additionally, the company may pursue strategic partnerships or distribution agreements to enter new geographic markets, including Asia-Pacific and Europe. With a robust product portfolio and a clear focus on peripheral nerve surgery, Checkpoint Surgical is well-positioned to capture a larger share of this specialized market.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation nerve stimulator80% success
• Q2 2026Publication of clinical outcomes data in peer-reviewed journal70% success
• Q4 2026Strategic partnership for international distribution60% success